WITHDRAWN: Hypericin-based Photodynamic Therapy Induces a Tumor-Specific Immune Response and an Effective DC-based cancer Immunotherapy
Authors:
- 1 February 2014
- journal article
- withdrawal
- Published by Elsevier in Biochemical Pharmacology
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Immunogenic Cell Death in Cancer TherapyAnnual Review of Immunology, 2013
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathThe EMBO Journal, 2012
- Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulinCancer Immunology, Immunotherapy, 2011
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in MiceScience, 2011
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012Cell Death & Differentiation, 2011
- Decoding Cell Death Signals in Inflammation and ImmunityCell, 2010
- Immunogenic death of colon cancer cells treated with oxaliplatinOncogene, 2009
- Immunogenic and tolerogenic cell deathNature Reviews Immunology, 2009
- Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell deathThe EMBO Journal, 2009
- The immune response against dying tumor cells: avoid disaster, achieve cureCell Death & Differentiation, 2007